Cornerstone Investment Partners, LLC Bristol Myers Squibb CO Transaction History

Cornerstone Investment Partners, LLC

$1.91 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	SELL	$48.48 - $57.85 $6,156 - $7,346	-127 Reduced 1.11%	11,270 $578,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $6,078 - $6,796	-105 Reduced 0.91%	11,397 $661,000
Q4 2022 Feb 01, 2023	SELL	$68.48 - $81.09 $2,465 - $2,919	-36 Reduced 0.31%	11,502 $828,000
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $230,568 - $253,936	-3,175 Reduced 21.58%	11,538 $888,000
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $43.9 Million - $52.6 Million	-714,164 Reduced 97.98%	14,713 $1.07 Million
Q4 2021 Feb 07, 2022	BUY	$53.63 - $62.52 $2.57 Million - $3 Million	47,943 Added 7.04%	728,877 $45.4 Million
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $3.96 Million - $4.63 Million	-66,848 Reduced 8.94%	680,934 $40.3 Million
Q2 2021 Jul 29, 2021	SELL	$61.91 - $67.42 $742,300 - $808,365	-11,990 Reduced 1.58%	747,782 $50 Million
Q1 2021 Apr 26, 2021	BUY	$59.34 - $66.74 $8.39 Million - $9.44 Million	141,372 Added 22.86%	759,772 $48 Million
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $3.75 Million - $4.25 Million	64,997 Added 11.74%	618,400 $38.4 Million
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $31.3 Million - $34.6 Million	544,248 Added 5944.82%	553,403 $33.4 Million
Q2 2020 Jul 30, 2020	SELL	$54.82 - $64.09 $1,918 - $2,243	-35 Reduced 0.38%	9,155 $538,000
Q1 2020 Apr 27, 2020	SELL	$46.4 - $67.43 $1,484 - $2,157	-32 Reduced 0.35%	9,190 $512,000
Q2 2019 Jul 19, 2019	SELL	$44.62 - $49.34 $24,184 - $26,742	-542 Reduced 5.55%	9,222 $418,000
Q1 2019 Apr 26, 2019	BUY	$45.12 - $53.8 $6,000 - $7,155	133 Added 1.38%	9,764 $466,000
Q4 2018 Jan 11, 2019	SELL	$48.76 - $63.23 $1,901 - $2,465	-39 Reduced 0.4%	9,631 $501,000
Q3 2018 Oct 19, 2018	BUY	$55.19 - $62.25 $6,126 - $6,909	111 Added 1.16%	9,670 $600,000
Q1 2018 Apr 04, 2018	SELL	$59.92 - $68.98 $1,498 - $1,724	-25 Reduced 0.26%	9,559 $605,000
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $574,464 - $626,314	-9,584 Reduced 50.0%	9,584 $587,000
Q4 2017 Jan 22, 2018	BUY	$59.94 - $65.35 $574,464 - $626,314	9,584 Added 100.0%	19,168 $1.18 Million
Q3 2017 Nov 08, 2017	SELL	$55.23 - $63.74 $529,324 - $610,884	-9,584 Reduced 50.0%	9,584 $611,000
Q3 2017 Oct 12, 2017	BUY	$55.23 - $63.74 $1.06 Million - $1.22 Million	19,168	19,168 $0

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.32 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.46 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.58 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.58 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Investment Partners, LLC with notifications on news.

Account